艾可蓝(300816) - 2022 Q1 - 季度财报(更正)

Financial Performance - The company's operating revenue for Q1 2022 was ¥230,173,177.24, representing a 22.60% increase compared to ¥187,737,584.55 in the same period last year[3] - The net profit attributable to shareholders decreased by 58.17% to ¥13,000,390.56 from ¥31,078,187.91 year-on-year[3] - The basic earnings per share dropped by 58.46% to ¥0.162 from ¥0.390 in the same period last year[3] - The net profit for Q1 2022 was CNY 12,981,237.88, a decrease of 57.7% compared to CNY 30,721,002.57 in Q1 2021[23] - Operating profit for Q1 2022 was CNY 11,464,812.63, down from CNY 35,418,436.55 in the same period last year, reflecting a decline of 67.7%[23] - The total profit for Q1 2022 was CNY 12,604,108.33, a decrease of 64.5% compared to CNY 35,567,324.65 in Q1 2021[23] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥6,845,345.71, a decline of 117.46% compared to ¥39,198,754.92 in the previous year[3] - The cash flow from operating activities showed a net outflow of CNY -6,845,345.71 in Q1 2022, compared to a net inflow of CNY 39,198,754.92 in Q1 2021[27] - Cash and cash equivalents at the end of Q1 2022 amounted to CNY 324,197,415.76, up from CNY 160,181,654.15 at the end of Q1 2021, indicating a significant increase of 102.5%[28] - The company's cash and cash equivalents at the end of the quarter were RMB 373,719,886.04, compared to RMB 289,258,131.49 at the beginning of the year[18] - Investment activities generated a net cash inflow of CNY 77,558,718.08 in Q1 2022, a recovery from a net outflow of CNY -173,703,031.68 in Q1 2021[27] Expenses and Costs - The company reported a significant increase in management expenses by 166.62% due to the consolidation of ABF and increased consulting fees[8] - Research and development expenses rose by 76.17% as a result of the consolidation of ABF[8] - The total operating costs amounted to RMB 226,845,989.78, up 39.4% from RMB 162,731,370.98 year-on-year[21] - The operating cost specifically rose to RMB 176,864,243.79, which is a 32.0% increase from RMB 133,989,629.70 in the previous year[21] - Research and development expenses reached RMB 17,123,847.74, reflecting a significant increase of 76.5% compared to RMB 9,719,877.98 in the prior year[21] - The company experienced a 328.70% increase in financial expenses due to increased loans[8] - The company reported a decrease in financial expenses to CNY 3,508,904.29 in Q1 2022 from CNY 818,503.04 in Q1 2021, indicating a significant increase in financial costs[23] Assets and Equity - The total assets at the end of the reporting period were ¥1,774,807,542.53, a slight increase of 1.02% from ¥1,756,825,074.16 at the end of the previous year[4] - The company's equity attributable to shareholders increased by 3.31% to ¥845,142,339.34 from ¥818,033,368.01 at the end of the previous year[4] - Total assets increased to RMB 1,774,807,542.53 from RMB 1,756,825,074.16 at the start of the year[20] - The company's total equity rose to RMB 851,595,902.79, up from RMB 824,506,084.13 at the start of the year[20] - Total liabilities decreased slightly to RMB 923,211,639.74 from RMB 932,318,990.03 at the beginning of the year[19] Inventory and Receivables - The company reported a decrease in accounts receivable to RMB 204,635,918.28 from RMB 221,436,694.64[18] - Inventory increased to RMB 261,837,363.54, compared to RMB 212,692,771.62 at the beginning of the year, indicating a growth of 23.0%[18] Government Subsidies - The company received government subsidies amounting to ¥3,649,825.17, which were included in non-operating income[6] - The company received CNY 2,222,742.00 in tax refunds during Q1 2022, compared to CNY 1,613,490.31 in Q1 2021, marking an increase of 37.7%[25]